 |
Abcuro
Last updated: February 02, 2024
Founder Stefano Gullà
Country: USA | Funding: $214.8M (+)
Website: https://www.abcuro.com/
Abcuro develops first-in-class immunotherapies to treat autoimmunity and cancer.
Website: https://www.abcuro.com/
Abcuro develops first-in-class immunotherapies to treat autoimmunity and cancer.